Omeprazole does not affect measured CYP3A4 activity using the erythromycin breath test [letter]
Open Access
- 1 October 1995
- journal article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 40 (4) , 411-412
- https://doi.org/10.1111/j.1365-2125.1995.tb04566.x
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Identification of human liver cytochrome P450 isoforms mediating omeprazole metabolismBritish Journal of Clinical Pharmacology, 1993
- Terfenadine-Ketoconazole InteractionJAMA, 1993
- A study of the interaction of omeprazole and warfarin in anticoagulated patients.British Journal of Clinical Pharmacology, 1992
- Omeprazole Drug Interaction StudiesClinical Pharmacokinetics, 1991
- OmeprazoleDrugs, 1991
- The erythromycin breath test as a predictor of cyclosporine blood levelsClinical Pharmacology & Therapeutics, 1990
- Erythromycin breath test as an assay of glucocorticoid-inducible liver cytochromes P-450. Studies in rats and patients.Journal of Clinical Investigation, 1989
- Oral phenytoin pharmacokinetics during omeprazole therapy.British Journal of Clinical Pharmacology, 1987
- The mechanism of action of omeprazole—a survey of its inhibitory actionsin vitroScandinavian Journal of Gastroenterology, 1985